Osteogenic differentiation and immune response of human bone-marrow-derived mesenchymal stem cells on injectable calcium-silicate-based bone grafts

Tissue Engineering - Part A

Volumn 16, Issue 7, 2010, Pages 2343-2354

  Ding, Shinn Jyh ^a,b   Shie, Ming You ^c   Hoshiba, Takashi ^d   Kawazoe, Naoki ^d   Chen, Guoping ^d   Chang, Hsien Chang ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; BONE CEMENT; CALCIUM; CELL CULTURE; CEMENTS; ENZYME ACTIVITY; IMMUNOLOGY; NITRIC OXIDE; SILICATES; STEM CELLS;

BONE GRAFT; BONE SIALOPROTEINS; CALCIUM SILICATE CEMENT; CELL VIABILITY; CHITOSAN OLIGOSACCHARIDE; CLINICAL APPLICATION; EXTRACELLULAR MATRIX COMPONENTS; GLYCOSAMINOGLYCANS; HUMAN BONES; HYDRATION REACTION; IMMUNE RESPONSE; IN-VITRO BIOACTIVITY; INDUCIBLE NITRIC OXIDE SYNTHASE; INJECTABILITY; INTERLEUKIN-1; INTERLEUKIN-10; LIQUID PHASE; MESENCHYMAL STEM CELL; OSTEOCALCIN; OSTEOGENESIS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; SETTING TIME; SOLID-PHASE;

CALCIUM SILICATE;

CALCIUM; CALCIUM DERIVATIVE; CALCIUM SILICATE; SILICATE;

ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE TRANSPLANTATION; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CYTOLOGY; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; INJECTION; MESENCHYMAL STEM CELL; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TENSILE STRENGTH; TIME; TRANSPLANTATION; ULTRASTRUCTURE; X RAY DIFFRACTION;

BONE MARROW CELLS; BONE TRANSPLANTATION; CALCIUM; CALCIUM COMPOUNDS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; INJECTIONS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SILICATES; TENSILE STRENGTH; TIME FACTORS; TRANSPLANTS; X-RAY DIFFRACTION;

EID: 77954529350     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0749     Document Type: Article

References (42)

1. Link, D.P., van den Dolder, J., Wolke, J.G.C., and Jansen, J.A. The cytocompatibility and early osteogenic characteristics of an injectable calcium phosphate cement. Tissue Eng 13, 493, 2007.
2. 4 as an accelerant. J Endod 34, 748, 2008.
3. Bohner, M., and Baroud, G. Injectability of calcium phosphate pastes. Biomaterials 26, 1553, 2005.
4. Khairoun, I., Boltong, M.G., Driessens, F.C.M., and Planell, J.A. Some factors controlling the injectability of calcium phosphate bone cements. J Mater Sci Mater Med 9, 425, 1998.
5. Rocha Alves, H.L., dos Santos, L.A., and Bergmann, C.P. Injectability evaluation of tricalcium phosphate bone cement. J Mater Sci Mater Med 19, 2241, 2008.
6. Takechi, M., Miyamoto, Y., Ishikawa, K., Yuasa, M., Na-gayama, M., Kon, M., and Asaoka, K. Non-decay type fast-setting calcium phosphate cement using chitosan. J Mater Sci Mater Med 7, 317, 1996.
7. Khairoun, I., Driessens, F.C.M., Boltong, M.G., Planell, J.A., and Wenz, R. Addition of cohesion promotors to calcium phosphate cements. Biomaterials 20, 393, 1999.
8. Fujishiro, Y., Takahashi, K., and Sato, T. Preparation and compressive strength of a-tricalcium phosphate/gelatin gel composite cement. J Biomed Mater Res 54, 525, 2001.
9. Yokoyama, A., Yamamoto, S., Kawasaki, T., Kohgo, T., and Nakasu, M. Development of calcium phosphate cement using chitosan and citric acid for bone substitute materials. Biomaterials 23, 1091, 2002.
10. Bigi, A., Bracci, B., and Panzavolta, S. Effect of added gelatin on the properties of calcium phosphate cement. Biomaterials 25, 2893, 2004.
11. Liu, H., Li, H., Cheng, W., Yang, Y., Zhu, M., and Zhou, C. Novel injectable calcium phosphate/chitosan composites for bone substitute materials. Acta Biomater 2, 557, 2006.
12. Shie, M.Y., Chen, C.H., Wang, C.Y., Chiang, T.Y., and Ding, S.J. Immersion behavior of gelatin-containing calcium phosphate cement. Acta Biomater 4, 646, 2008.
13. Khairoun, I., Driessens, F.C., Boltong, M.G., Planell, J.A., and Wenz, R. Addition of cohesion promotors to calcium phosphate cements. Biomaterials 20, 393, 1999.
14. Panzavolta, S., Fini, M., Nicoletti, A., Bracci, B., Rubini, K., Giardino, R., and Bigi, A. Porous composite scaffolds based on gelatin and partially hydrolyzed a-tricalcium phosphate. Acta Biomater 5, 636, 2009.
15. Olsen, D., Yang, C., Bodo, M., Chang, R., Leigh, S., Baez, J., Carmichaela, D., Perä lä, M., Hämäläinen, E., Jarvinen, M., and Polarek, J. Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev 55, 1547, 2003.
16. Kim, S.K., and Rajapakse, N. Enzymatic production and biological activities of chitosan oligosaccharides (COS): a review. Carbohydr Polym 62, 357, 2005.
17. Li, D.X., Fan, H.S., Zhu, X.D., Tan, Y.F., Xiao, W.K., Lu, J., Xiao, Y.M., Chen, A.J.Y., and Zhang, A.X.D. Controllable release of salmon-calcitonin in injectable calcium phosphate cement modified by chitosan oligosaccharide and collagen polypeptide. J Mater Sci Mater Med 18, 2225, 2007.
18. Chiang, T.Y., Ho, C.C., Chen, C.H., Lai, M.H., and Ding, S.J. Physicochemical properties and biocompatibility of chitosan oligosaccharide/ gelatin/calcium phosphate hybrid cements. Mater Chem Phys 120, 282, 2010.
19. Chen, C.C., Ho, C.C., Chen, C.H., and Ding, S.J. Physico-chemical properties of calcium silicate cements for end-odontic treatment. J Endod 35, 1288, 2009.
20. Ding, S.J., Shie, M.Y., and Wang, C.Y. Novel fast-setting calcium silicate bone cements with high bioactivity and enhanced osteogenesis in vitro. J Mater Chem 19, 1183, 2009.
21. Chen, C.C., Ho, C.C., Chen, C.H., Wang, W.C., and Ding, S.J. In vitro bioactivity and biocompatibility of dicalcium silicate cements for endodontic use. J Endod 35, 1554, 2009.
22. Zhao, W., Wang, J., Zhai, W., Wang, Z., and Chang, J. The self-setting properties and in vitro bioactivity of tricalcium silicate. Biomaterials 26, 6113, 2005.
23. 4. J Biomed Mater Res 73B, 244, 2005.
24. Lenas, P., Moos, M., and Luyten, F.P. Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part I: from three-dimensional cell growth to biomimetics of in vivo development. Tissue Eng B 15, 381, 2009.
25. Francis Suh, J.K., and Matthew, H.W.T. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 21, 2589, 2000.
26. Chen, C.C., Lai, M.H., Wang, W.C., and Ding, S.J. Properties of anti-washout-type calcium silicate bone cements containing gelatin. J Mater Sci Mater Med, DOI: 10.1007/s10856-009-3948-1.
27. Bentz, D.P. Cement hydration: building bridges and dams at the microstructure level. Mater Struct 40, 397, 2007.
28. Wang, X., Feng, Q.L., Cui, F.Z., and Ma, J. The effects of S-chitosan on the physical properties of calcium phosphate cements. J Bioactive Compatible Polym 18, 45, 2003.
29. Freemont, A.J. Histology of mineralized tissues. In: Huskins, D.W.L., ed. Topics in Molecular and Structural Biology, 11. Calcified Tissue. London: The Macmillan Press, 1993, pp. 21-40.
30. Bigi, A., Panzavolta, S., Sturba, L., Torricelli, P., Fini, M., and Giardino, R. Normal and osteopenic bone-derived osteoblast response to a biomimetic gelatin-calcium phosphate bone cement. J Biomed Mater Res 78A, 739, 2006.
31. Pierschbacher, M.D., and Ruoslahti, E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309, 30, 1984.
32. Garcia, A.J., and Reyes, C.D. Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. J Dent Res 84, 407, 2005.
33. Remes, A., and Williams, D.F. Immune response in bio-compatibility. Biomaterials 13, 731, 1992.
34. van't Hof, R.J., and Ralston, S.T. Nitric oxide and bone. Immunology 103, 255, 2001.
35. Nussler, A.K., and Billiar, T.R. Inflammation, immunoregu-lation, and inducible nitric oxide synthase. J Leukoc Biol 54, 171, 1993.
36. Akira, S., Hirano, T., Taga, T., and Kishimoto, T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4, 2860, 1990.
37. Kawai, T., and Akira, S. Innate immune recognition of viral infection. Nat Immunol 7, 131, 2006.
38. Granchi, D., Ciapetti, G., Savarino, L., Cenni, E., Pizzo-ferrato, A., Baldini, N., and Giunti, A. Effects of bone cement extracts on the cell-mediated immune response. Biomaterials 23, 1033, 2002.
39. Xu, L.X., Kukita, T., Kukita, A., Otsuka, T., Niho, Y., and Iijima, T. Interleukin-10 selectively inhibits osteoclasto-genesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system. J Cell Physiol 165, 624, 1995.
40. Aubin, J.E., Liu, F., Malaval, L., and Gupta, A.K. Osteoblast and chondroblast differentiation. Bone 17, 77S, 1995.
41. Hunter, G., and Goldberg, H.A. Nucleation of hydroxy-apatite by bone sialoprotein. Proc Natl Acad Sci USA 90, 8562, 1993.
42. Gough, J.E., Jones, J.R., and Hench, L.L. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 25, 2039, 2004.